InvestorsHub Logo
Followers 17
Posts 3364
Boards Moderated 0
Alias Born 05/22/2011

Re: None

Friday, 02/17/2012 1:55:34 PM

Friday, February 17, 2012 1:55:34 PM

Post# of 5011
Scottsdale, Arizona, Feb 17, 2012 (PRWeb.com via COMTEX) -- QualityStocks would
like to highlight China Health Resource, Inc., a publicly traded company engaged
in the development, manufacturing, processing, marketing, and sale of Dahurian
Angelica Root (DAR) and related products in the People's Republic of China. DAR,
which is also known as "Bai Zhi" in Mandarin Chinese, is an herb that is
employed as an ingredient in medicine, cosmetics, and food, as well as in TCM
for the treatment of pain, swelling, and pustule. The company's DAR-related
products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant
Bag, all of which are sold through regional distributors.

In the company's news yesterday,

China Health Resource announced unaudited financial results for the fourth
quarter and year ended December 31, 2011.

The company expects 2011 fourth-quarter operating revenues of more than $12.5
million, a 218 percent increase compared to the fourth quarter of 2010. For full
year 2011, the company expects operating revenues of $34.9 million, a 241
percent increase over 2010 revenues.

China Health expects 2011 fourth-quarter net income to be $2.7 million, or
$0.015 per fully diluted common share, compared with $1.6 million or $0.01 per
share, reported for the fourth quarter of 2010. For full year 2011, the company
anticipates net income of $6.8 million, or $0.038 per fully diluted common
share, compared with a net income of$2.7 million, or $0.02 per share in the year
prior.

The company attributes its growth to the expansion of its TCM product lines,
improvements in sales channel management to extend market reach, and consistent
cost controls.

China Health also provided guidance for 2012 with a focus on growing its product
lines and implementing further growth initiatives.

The company anticipates 2012 earnings in the range of $0.06 and $0.065 per
share.

Jiayin Wang, President and CEO of CHRI, stated, "Speaking to the company's focus
in 2012, we will continue to maintain our leadership in our DAR franchise while
we grow our product lines with valuable and high growth products like
Gastrodiae. In addition, we will pursue growth opportunities worldwide through
acquisition and distribution and grow in areas where we can best serve customers
and create value."

China Health said it will provide detailed results in its final 2011 fourth
quarter and year-end earnings press release and 10-K filing.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects
data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into
one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging
public companies with their investor communication efforts and connecting
subscribers with companies that have huge potential to succeed in the short and
long-term future.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.